New Jersey S 179: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: S 179

Subjects: DISEASE, HEALTH PROF

Sponsors: Corrado, Kristin M.

View New Jersey S 179 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.